Sign Up Today and Learn More About Genome Medical Stock
Invest in or calculate the value of your shares in Genome Medical or other pre-IPO companies through EquityZen's platform.
Genome Medical Stock (GEME)
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
About Genome Medical Stock
Founded
2016
Headquarters
South San Francisco, CA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. The company was founded in 2016 and is based in South San Francisco, California, United States.
Genome Medical Press Mentions
Stay in the know about the latest news on Genome Medical
Genome Medical and Nest Genomics Partner to Scale Access to Genetic Services and Improve Patient Care
einpresswire • Jan 16, 2025
Genome Medical Announces Strategic Pivot to Focus on Rare Disease Specialty
einpresswire • Jan 10, 2025
PatientsLikeMe Partners with Genome Medical to Expand Access to Genetic Care and Improve Patient Outcomes
prweb • Dec 10, 2024
Genetic Testing Delivers Startup Hits And Misses
news • Nov 20, 2024
Parakeet Health: $3 Million (Seed) Closed To Improve Patient Engagement For Healthcare Providers
pulse2 • Nov 01, 2024
Genome Medical Management
Leadership team at Genome Medical
Co-Founder & CEO
Lisa Alderson
Co-Founder
Robert Green
Join now and verify your accreditation status to gain access to:
- Genome Medical Current Valuation
- Genome Medical Stock Price
- Genome Medical Management
- Available deals in Genome Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Genome Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Genome Medical Revenue and Financials
- Genome Medical Highlights
- Genome Medical Business Model
- Genome Medical Risk Factors
- Genome Medical Research Report from SACRA Research
Trading Genome Medical Stock
How to invest in Genome Medical stock?
Accredited investors can buy pre-IPO stock in companies like Genome Medical through EquityZen funds. These investments are made available by existing Genome Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genome Medical stock?
Shareholders can sell their Genome Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
